Capecitabine-Associated Terminal Ileitis.

van Hellemond, Irene E G; Thijs, Annemarie M; Creemers, Geert-Jan

van Hellemond, Irene E G; Thijs, Annemarie M; Creemers, Geert-Jan.

Afiliación

van Hellemond IEG; Department of Internal Medicine, Catharina Hospital, Eindhoven, the Netherlands.
Thijs AM; Department of Internal Medicine, Catharina Hospital, Eindhoven, the Netherlands.
Creemers GJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, the Netherlands.

Case Rep Oncol ; 11(3): 654-659, 2018.

Article en En | MEDLINE | ID: mdl-30483093

RESUMEN

Capecitabine is an oral fluoropyrimidine used as adjuvant and palliative chemotherapy in patients with colorectal cancer. Diarrhea is a well-known side effect of capecitabine and 5-fluorouracil agents. We present a case with terminal ileitis as a rare adverse event of capecitabine treatment. Capecitabine-induced terminal ileitis is likely to be underreported. It should be considered more often as a cause of severe and atypical complaints of diarrhea during treatment with capecitabine or other 5-fluorouracil agents.

Palabras clave

Adverse event; Capecitabine; Colorectal cancer; Diarrhea; Fluoropyrimidine; Terminal Ileitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Case Rep Oncol Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google